Charles Schwab Investment Management Inc. Lowers Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Charles Schwab Investment Management Inc. cut its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 29.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 429,689 shares of the biotechnology company’s stock after selling 180,321 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 0.57% of Axon Enterprise worth $171,704,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. O Shaughnessy Asset Management LLC increased its holdings in shares of Axon Enterprise by 55.4% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 1,986 shares of the biotechnology company’s stock valued at $621,000 after acquiring an additional 708 shares during the period. EP Wealth Advisors LLC lifted its holdings in shares of Axon Enterprise by 6.6% during the 1st quarter. EP Wealth Advisors LLC now owns 1,333 shares of the biotechnology company’s stock valued at $417,000 after purchasing an additional 83 shares during the last quarter. BOKF NA boosted its position in shares of Axon Enterprise by 52.7% in the 1st quarter. BOKF NA now owns 9,465 shares of the biotechnology company’s stock worth $2,947,000 after purchasing an additional 3,268 shares in the last quarter. Zurich Insurance Group Ltd FI grew its stake in Axon Enterprise by 0.3% during the 1st quarter. Zurich Insurance Group Ltd FI now owns 201,183 shares of the biotechnology company’s stock worth $62,946,000 after buying an additional 526 shares during the last quarter. Finally, Bayesian Capital Management LP purchased a new position in Axon Enterprise during the 1st quarter worth $2,350,000. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In other news, CFO Brittany Bagley sold 4,338 shares of the stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the sale, the chief financial officer now directly owns 98,825 shares of the company’s stock, valued at $37,449,733.75. This represents a 4.20 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the transaction, the insider now owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. This represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 330,256 shares of company stock valued at $131,338,820. Corporate insiders own 6.10% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Needham & Company LLC raised their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. JMP Securities boosted their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Barclays raised their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Robert W. Baird lifted their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Finally, Craig Hallum upped their target price on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus target price of $427.83.

Axon Enterprise Stock Up 0.9 %

Shares of AXON stock opened at $636.95 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a twelve month low of $224.28 and a twelve month high of $641.20. The stock has a 50 day moving average of $463.58 and a 200 day moving average of $368.07. The stock has a market cap of $48.57 billion, a P/E ratio of 164.59, a P/E/G ratio of 18.89 and a beta of 0.94.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.